InvestorsHub Logo
Followers 1055
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Monday, 03/13/2017 5:46:26 PM

Monday, March 13, 2017 5:46:26 PM

Post# of 513
Solid News Out.Cap is only 20m vs "C.difficile has been categorized as an urgent threat by the Centers for Disease Control. According to published research reports, treatment costs in the United States and Europe are estimated at $7 billion" annually.

https://www.streetinsider.com/Corporate+News/Stellar+Biotechnologies+(SBOT)+to+Sell+Immunogen+%26+Vaccine+Technology+to+Matrivax/12662692.html

Impressive upside potential if you ask me. very solid balance sheet (no debt),$9.88m Cash on hand and only 10m o/s (13m fully diluted).

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EDSA News